KCNN4 promotes the progression of lung adenocarcinoma by activating the AKT and ERK signaling pathways

Abstract

This study investigated the function and mechanism of KCNN4 in lung adenocarcinoma. On this basis, this means that KCNN4 can be used as a tumor marker for lung adenocarcinoma and is expected to become an important target for a potential drug.